What is Collegium Pharmaceutical, Inc.'s D&A?

Collegium Pharmaceutical, Inc. (COLL) reported D&A of $463K in Q1 2026.

How has Collegium Pharmaceutical, Inc.'s D&A changed year-over-year?

Collegium Pharmaceutical, Inc.'s D&A decreased by 57.6% year-over-year, from $1.09M to $463K.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s D&A?

Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s D&A has grown at a 24.6% compound annual growth rate (CAGR), from $1.74M to $4.18M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Collegium Pharmaceutical, Inc. COLL D&A

D&A at other companies

Indivior Pharmaceuticals, Inc. INDV

$2M-33.3%

Catalyst PharmaceuticalCPRX

$70K-39.1%

Avanos MedicalAVNS

$10.2M+6.3%

Pacira BioSciences, Inc.PCRX

$21.33M+0.8%

Supernus PharmaceuticalsSUPN

$26.13M+28.2%

Theravance BiopharmaTBPH

$381K-7.7%

Other financials

Income statement

See full

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

See full

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

See full

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

See full

Market cap$1.15B+20.4%

Enterprise value$869.67M+2.5%

P/E15.4×-6.4×

P/S1.5×0.0×

Profitability

See full

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

Net margin9.4%+2.8pp

FCF margin41.4%+10.4pp

Returns & leverage

See full

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s D&A?: Collegium Pharmaceutical, Inc. (COLL) reported D&A of $463K in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s D&A changed year-over-year?: Collegium Pharmaceutical, Inc.'s D&A decreased by 57.6% year-over-year, from $1.09M to $463K.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s D&A?: Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s D&A has grown at a 24.6% compound annual growth rate (CAGR), from $1.74M to $4.18M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.